November 08, 2009
– Comments (1) |
RELATED TICKERS: BVF.DL
The new healthcare bill focuses on getting people cheaper generic drugs, so while brand name big pharma companies lose out, the little guys that sell generic drugs should rally.
The "little guys that sell generic drugs" don't focus on R&D. The big pharma companies are the ones who shoulder that financial load. When the patents run out, the big pharma companies make a slight change to the molecule, rename/rebrand it and keep on selling at a higher price point.
Now, if the big pharma companies are going to lose out, the implication is they will have less money. Less money means less R&D. Less R&D means fewer new drugs to patent. Fewer new drugs to patent means fewer drugs coming off patent and able to be made "generic." The little guys that sell generic drugs are losing out, too. Most people just haven't realized it yet.
OTOH, maybe the big pharma companies will keep paying for all that R&D out of the goodness of their hearts and desire to keep the people healthy.
All that being said, I think far too many people buy the "take a pill" solution for every little thing. This idiocy feeds in to the need to have the patent/generic game going on.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by